New Delhi: Sanofi and GSK have received approval for their phase 3 clinical studies in India to assess safety, efficacy,…
Another Covid-19 vaccine Moves final trials
PARIS: Generation of the following possible vaccine from Covid-19 will start within fourteen days, its programmers Sanofi and GlaxoSmithKline said…